Gene · 90
Papers2,859
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,181 to 1,200 of 2,859
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression. | J Exp Clin Cancer Res | 2020 | 32771045 | PubTator, text mining | PubMed |
| Soft Matrix Combined With BMPR Inhibition Regulates Neurogenic Differentiation of Human Umbilical Cord Mesenchymal Stem Cells. | Front Bioeng Biotechnol | 2020 | 32760710 | PubTator, text mining | PubMed |
| Activin-A Induces Fewer, but Larger Osteoclasts From Monocytes in Both Healthy Controls and Fibrodysplasia Ossificans Progressiva Patients. | Front Endocrinol (Lausanne) | 2020 | 32760351 | PubTator, text mining | PubMed |
| A kinase inhibitor screen identifies signaling pathways regulating mucosal growth during otitis media. | PLoS One | 2020 | 32760078 | PubTator, text mining | PubMed |
| RAP-011 Rescues the Disease Phenotype in a Cellular Model of Congenital Dyserythropoietic Anemia Type II by Inhibiting the SMAD2-3 Pathway. | Int J Mol Sci | 2020 | 32759740 | PubTator, text mining | PubMed |
| miR-18a Inhibits BMP4 and HIF-1α Normalizing Brain Arteriovenous Malformations. | Circ Res | 2020 | 32755283 | PubTator, text mining | PubMed |
| Tailored Teaching for Specialized (Para-)medical Students - Experience From Incorporating a Relevant Genetic Disease Throughout a Course of Molecular Cell Biology. | Front Public Health | 2020 | 32754565 | PubTator, text mining | PubMed |
| Discovery, synthesis and characterization of a series of 7-aryl-imidazo[1,2-a]pyridine-3-ylquinolines as activin-like kinase (ALK) inhibitors. | Bioorg Med Chem Lett | 2020 | 32750526 | PubTator, text mining | PubMed |
| Identification of sulfakinin receptors (SKR) in Tenebrio molitor beetle and the influence of sulfakinins on carbohydrates metabolism. | J Comp Physiol B | 2020 | 32749519 | PubTator, text mining | PubMed |
| The role of bone morphogenetic protein signaling in vascular calcification. | Bone | 2020 | 32736145 | PubTator, text mining | PubMed |
| Fibrodysplasia ossificans progressiva (FOP): A disorder of osteochondrogenesis. | Bone | 2020 | 32730934 | PubTator, text mining | PubMed |
| Structural perspective of BMP ligands and signaling. | Bone | 2020 | 32730927 | PubTator, text mining | PubMed |
| Patients with ACVR1R206H mutations have an increased prevalence of cardiac conduction abnormalities on electrocardiogram in a natural history study of Fibrodysplasia Ossificans Progressiva. | Orphanet J Rare Dis | 2020 | 32727600 | PubTator, text mining | PubMed |
| A Clinical Perspective on Advanced Developments in Bone Biopsy Assessment in Rare Bone Disorders. | Front Endocrinol (Lausanne) | 2020 | 32714279 | PubTator, text mining | PubMed |
| The Epstein-Barr Virus-Encoded EBNA1 Protein Activates the Bone Morphogenic Protein (BMP) Signalling Pathway to Promote Carcinoma Cell Migration. | Pathogens | 2020 | 32708289 | PubTator, text mining | PubMed |
| NRH salvage and conversion to NAD+ requires NRH kinase activity by adenosine kinase. | Nat Metab | 2020 | 32694608 | PubTator, text mining | PubMed |
| Global activation of oncogenic pathways underlies therapy resistance in diffuse midline glioma. | Acta Neuropathol Commun | 2020 | 32680567 | PubTator, text mining | PubMed |
| UTX Regulates Human Neural Differentiation and Dendritic Morphology by Resolving Bivalent Promoters. | Stem Cell Reports | 2020 | 32679064 | PubTator, text mining | PubMed |
| Predicting and Promoting Human Bone Marrow MSC Chondrogenesis by Way of TGFβ Receptor Profiles: Toward Personalized Medicine. | Front Bioeng Biotechnol | 2020 | 32676497 | PubTator, text mining | PubMed |
| Mutant FOXL2C134W Hijacks SMAD4 and SMAD2/3 to Drive Adult Granulosa Cell Tumors. | Cancer Res | 2020 | 32641411 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/90/papers?page=60